ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Antioxidant treatment could halt neurodegeneration in early Parkinson's

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

 
Print Page
Email Article

Arthritis Drug Suppresses Cancer Development by Stopping Action of Key Protein

  [ 58 votes ]   [ Discuss This Article ]
www.ProHealth.com • April 7, 2003


Researchers at The University of Texas M. D. Anderson Cancer Center have, for the first time, identified the molecular pathway by which a commonly prescribed arthritis medication inhibits the growth of cancer.

Before this study, scientists had linked use of celecoxib capsules (commonly known as Celebrex) to prevention of cancer, but the way in which the medication acted in cancer cells was unknown.

Now, investigators have found that celecoxib capsules stop a key transcription factor known as Sp1 from turning on multiple genes in cancer cells known to be associated with cancer growth. One of those genes triggers production of vascular endothelial growth factor (VEGF), the predominant angiogenic factor that leads blood vessels to grow to feed tumors.

The findings were published in the Proceedings for the 2003 Annual Meeting of the American Association for Cancer Research.

"Our results provide a novel molecular mechanism for the antitumor activity of celecoxib," says Keping Xie, M.D., Ph.D., assistant professor in the department of gastrointestinal medical oncology.

Xie adds that although the study was conducted in models of pancreatic cancer, the results likely describe how celecoxib interferes with development of a number of common cancers that all involve the Sp1/VEGF pathway.

"Pancreatic cancer overexpresses Sp1, which then drives VEGF overexpression," says Xie. "This same molecular activity is also found in colon, prostate, gastric and breast cancer."

Now that the mechanism by which celecoxib inhibits cancer growth is known, it may be possible to tailor the drug to be even more powerful, Xie says. Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) known as a cox-2 inhibitor, and this new study demonstrates that cox-2 inhibits VEGF through the Sp1 transcription factor.

The researchers used both pancreatic cell cultures and an animal model of the disease to draw their conclusions. They treated pancreatic cancer cells with celecoxib and found it suppressed VEGF at both the genetic level (messenger RNA) and at protein expression, in a dose-dependent manner _ increasing amounts of the drug produced increasing suppression. Laboratory tests then demonstrated that celecoxib treatment reduced the ability of Sp1 to promote genetic activity, and studies with a pancreatic cancer animal model showed the drug inhibited tumor growth and metastasis, which correlated with reduced VEGF expression.

"The antitumor activity was consistent with inhibition of angiogenesis as determined by evaluating tumor microvessel formation, which correlated with decreased Sp1 activity and VEGF expression," says Xie.



Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

When a Negative is Positive - Goodnighties Recovery Sleepwear When a Negative is Positive - Goodnighties Recovery Sleepwear
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
Strengthen Cell Function with Energy-Boosting Niagen Strengthen Cell Function with Energy-Boosting Niagen
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map